Examkin

Soru

Zorluk: Çok zorEndocrine and Metabolic Mechanisms

A 58-year-old woman with a history of recurrent nephrolithiasis and severe osteoporosis is evaluated in the clinic. Laboratory studies show a serum calcium of 11.2 mg/dL, serum phosphorus of 2.1 mg/dL, and an intact parathyroid hormone level of 145 pg/mL (normal: 10-65 pg/mL). The physician explains that her hypophosphatemia is a direct result of the elevated hormone acting on the renal proximal tubules. Arrange the following cellular and molecular events in the correct chronological sequence by which this hormone decreases renal phosphate reabsorption.

  1. 1Binding of the hormone to a basolateral Gs-protein-coupled receptor
  2. 2Activation of adenylate cyclase and generation of intracellular cyclic AMP
  3. 3Activation of the cytosolic enzyme protein kinase A (PKA)
  4. 4Phosphorylation of scaffolding proteins, including NHERF-1
  5. 5Internalization and lysosomal degradation of apical NaPi-IIa cotransporters

Cevap

The correct sequence begins with parathyroid hormone binding to the basolateral PTH1R receptor, followed by adenylate cyclase activation producing cAMP. This activates PKA, which phosphorylates NHERF-1, ultimately leading to the internalization and degradation of apical NaPi-IIa cotransporters.
Parathyroid hormone (PTH) exerts its phosphaturic effect on the renal proximal tubule via a well-defined intracellular signaling cascade. The sequence begins when PTH binds to the basolateral PTH1R receptor, a Gs-protein-coupled receptor. This interaction activates adenylate cyclase, leading to an increase in intracellular cyclic AMP (cAMP). The cAMP second messenger then binds to and activates protein kinase A (PKA). Once activated, PKA phosphorylates various intracellular targets, most notably the scaffolding protein NHERF-1 (Na+/H+ exchanger regulatory factor 1). In its unphosphorylated state, NHERF-1 effectively tethers the NaPi-IIa (sodium-phosphate) cotransporter to the actin cytoskeleton at the apical membrane. Phosphorylation of NHERF-1 causes the dissociation of this complex, triggering the rapid endocytosis of the NaPi-IIa cotransporter. Once internalized in vesicles, the transporter is directed to lysosomes for degradation. The loss of these transporters from the luminal surface directly results in decreased phosphate reabsorption and subsequent phosphaturia, presenting clinically as hypophosphatemia in patients with primary hyperparathyroidism.

Adım Adım Çözüm

1
Identify the primary hormone and its receptor target based on the clinical presentation.
The patient has primary hyperparathyroidism. PTH binds to the basolateral PTH1R receptor on proximal tubule cells.
PTH regulates phosphate reabsorption directly at the proximal tubule via a specific G-protein-coupled receptor.
2
Determine the immediate intracellular consequence of receptor activation.
The Gs alpha subunit activates adenylate cyclase, generating cyclic AMP (cAMP).
PTH1R primarily couples to Gs proteins in the kidney to mediate its phosphaturic effect.
3
Identify the downstream effector of the second messenger.
Cyclic AMP activates protein kinase A (PKA).
cAMP binds to the regulatory subunits of PKA, freeing the catalytic subunits to phosphorylate target proteins.
4
Determine the specific target of phosphorylation in this pathway.
PKA phosphorylates the scaffolding protein NHERF-1 (Na+/H+ exchanger regulatory factor 1).
NHERF-1 normally anchors the phosphate transporter to the actin cytoskeleton; phosphorylation uncouples it.
5
Identify the final cellular mechanism that reduces phosphate reabsorption.
The NaPi-IIa cotransporters are endocytosed and degraded in lysosomes.
Once uncoupled from the cytoskeleton, the transporters are removed from the apical membrane, physically preventing luminal phosphate uptake.

Anahtar Kavram

Parathyroid hormone (PTH) signal transduction pathway in the renal proximal tubule
Bu soruyu puanla

Konular

Endocrine and Metabolic Mechanisms

Bu konudan daha fazla soru